Do Firms Purposefully Change Capital Structure? Evidence from an Investment-Opportunity Shock to Drug Firms

Erasmo Giambona, Joseph Golec, Florencio Lopez-De-Silanes

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Do Firms Purposefully Change Capital Structure? Evidence from an Investment-Opportunity Shock to Drug Firms'. Together they form a unique fingerprint.

Business & Economics